📰 Twist Bioscience News
Page 3 - Twist Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Twist Bioscience. Real-time updates on events, politics, business and more.
April 10, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $33.73, but opened at $31.32. Twist Bioscience shares last traded at $31.44, with a volume of 94,932 shares changing hands. Analysts Set New Price Targets TWST has been the topic of […]
April 5, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) insider William Banyai sold 327 shares of Twist Bioscience stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $32.74, for a total value of $10,705.98. Following the transaction, the insider now directly owns 345,986 shares of the company’s stock, […]
April 5, 2024
Twist Bioscience Corporation ( NASDAQ:TWST ) shareholders might be concerned after seeing the share price drop 13% in...
March 28, 2024
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human...
March 24, 2024
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Takeda Pharmaceutical has a beta […]
March 12, 2024
/PRNewswire/ -- Gene Expression Analysis Market in terms of revenue was estimated to be worth $4.2 billion in 2024 and is poised to reach $6.2 billion by 2029,...
March 11, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) SVP Paula Green sold 600 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $37.43, for a total value of $22,458.00. Following the sale, the senior vice president now owns 92,850 shares of the company’s […]
March 1, 2024
Deutsche Bank AG increased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 4.8% in the third quarter, HoldingsChannel.com reports. The firm owned 51,208 shares of the company’s stock after buying an additional 2,368 shares during the quarter. Deutsche Bank AG’s holdings in Twist Bioscience were worth $1,037,000 at the end of the […]
March 1, 2024
Charles Schwab Investment Management Inc. raised its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 3.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 442,504 shares of the company’s stock after purchasing an additional 14,511 […]